IRPALIV Trademark

Trademark Overview


On Sunday, November 12, 2023, a trademark application was filed for IRPALIV with the United States Patent and Trademark Office. The USPTO has given the IRPALIV trademark a serial number of 98266432. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 11, 2025. This trademark is owned by Abbisko Therapeutics Co., Ltd.. The IRPALIV trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, medicinal preparations for the treatment of cancer; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer
irpaliv

General Information


Serial Number98266432
Word MarkIRPALIV
Filing DateSunday, November 12, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, medicinal preparations for the treatment of cancer; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbisko Therapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Party NameAbbisko Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Trademark Events


Event DateEvent Description
Wednesday, November 15, 2023NEW APPLICATION ENTERED
Thursday, December 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Thursday, June 27, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 28, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Monday, February 10, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 10, 2025ASSIGNED TO PETITION STAFF
Monday, February 10, 2025PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, February 20, 2025NOTICE OF ALLOWANCE CANCELLED
Thursday, February 20, 2025CASE RETURNED TO EXAMINATION
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED